Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many people ask whether they need to reach a certain weight before starting semaglutide therapy. The answer is more nuanced: FDA-approved semaglutide (Ozempic, Wegovy) uses BMI and clinical health status as eligibility markers, not raw weight alone. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies for patients who meet medical criteria, with personalized dosing that starts low and adjusts based on your individual response.
BMI vs. Weight: What Actually Determines Semaglutide Eligibility
Weight alone doesn't determine semaglutide eligibility because two people of the same weight can have very different health profiles. Body Mass Index (BMI), calculated from height and weight, is the standard metric used to assess whether semaglutide treatment is appropriate. For weight loss, typical eligibility thresholds are a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition like type 2 diabetes, high blood pressure, or sleep apnea.
A person weighing 180 pounds at 5'4" has a BMI of roughly 31, while someone weighing 180 pounds at 6'2" has a BMI around 23. This difference in BMI, not the shared weight, determines medical eligibility for semaglutide therapy. PlexusDx evaluates each patient individually to confirm they meet clinical guidelines before starting treatment.
Medical Conditions That Lower the BMI Threshold for Semaglutide
Having certain chronic conditions can make you eligible for semaglutide at a lower BMI. Type 2 diabetes, cardiovascular disease, hypertension, obstructive sleep apnea, and nonalcoholic fatty liver disease are established risk factors that may qualify you for treatment even if your BMI falls in the 27–29.9 range. The presence of these conditions signals that weight loss could significantly improve your health outcomes, which is why medical guidelines recognize them as eligibility criteria.
Your personal or family history of heart disease, stroke, or early mortality also strengthens the case for semaglutide therapy at a lower BMI threshold. PlexusDx works with you to assess your complete medical picture—not just your weight—to determine if semaglutide aligns with your health goals and risk profile.
How PlexusDx Personalizes Semaglutide Dosing Without Pricing Tiers
PlexusDx offers compounded semaglutide injections starting at $149 per month, with a core principle: your dose may need to go up, but your price won't. This flat-rate structure removes the complexity of dose-dependent pricing, so whether you begin at a microdose or scale up gradually, your monthly investment stays predictable. Compounded semaglutide from licensed 503A pharmacies allows for individualized starting doses and titration schedules tailored to your metabolic response and tolerance.
The Precision Peptide Genetic Test available through PlexusDx can further refine your treatment plan by analyzing how your body responds to GLP-1 receptor signaling, FTO pathways, and other peptide metabolism genes. For an additional $99 after your first month, this test maps 14 biological pathways and 150+ genetic insights, helping your provider optimize your semaglutide regimen for maximum efficacy and comfort.
Starting Semaglutide: No Minimum Weight, Clear Medical Guidelines
There is no absolute minimum weight requirement to start semaglutide, but you must meet BMI or clinical criteria that indicate weight loss would reduce your health risks. Patients often begin treatment in the overweight category (BMI 25–29.9) if they carry obesity-related conditions, while others start in the obese category (BMI ≥30). The key is demonstrating that semaglutide aligns with your medical needs, not hitting a specific number on the scale.
PlexusDx serves patients across all 50 states without requiring insurance, insurance pre-approval, or membership fees. Treatment is HSA and FSA eligible, making it accessible whether your eligibility stems from primary weight loss goals or weight-related comorbidities. A straightforward consultation with a PlexusDx provider will clarify whether you qualify and which formulation—injection or oral—suits your preferences and health profile.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the minimum weight to start semaglutide through PlexusDx?
There is no specific minimum weight. PlexusDx evaluates BMI and health conditions instead. Eligibility typically begins at BMI ≥30 or BMI ≥27 with weight-related conditions like diabetes or hypertension. Your provider will assess whether semaglutide fits your health profile during consultation.
Can I get semaglutide if I only have 20 pounds to lose?
Clinical eligibility depends on your BMI and medical history, not the absolute amount of weight you wish to lose. If your BMI and health factors support treatment, you may qualify even for modest weight loss goals. PlexusDx reviews your full health picture to make this determination.
How much does compounded semaglutide cost at PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month across all dose strengths. Your dose may increase as treatment progresses, but your monthly price stays the same. No insurance, membership fee, or prior approval is required.
Is compounded semaglutide from PlexusDx safe and legitimate?
Yes. PlexusDx sources all medications from licensed 503A compounding pharmacies, which operate under strict FDA oversight and state pharmacy board regulations. Compounded medications are not FDA-approved, but they are legally produced and widely used in clinical practice when brand-name alternatives are unavailable or unaffordable.
How can the Precision Peptide Genetic Test improve my semaglutide results?
The Precision Peptide Genetic Test ($99 add-on after month one) analyzes genetic variants in GLP1R, GIPR, FTO, MC4R, and 10 other peptide-metabolism pathways. This identifies how your body naturally responds to GLP-1 signaling, helping PlexusDx providers fine-tune your dose, formulation, and treatment strategy for better outcomes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Do You Give Yourself a Shot of Ozempic Properly
How Many People Take Compounded Semaglutide? Understanding the Growing Demand for Personalized Weight Loss Solutions